Hansoh Pharmaceutical Group Co (HKSE:03692) Gross-Profit-to-Asset % : 31.38% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Hansoh Pharmaceutical Group Co's annualized Gross Profit for the quarter that ended in Dec. 2023 was HK$11,150 Mil. Hansoh Pharmaceutical Group Co's average Total Assets over the quarter that ended in Dec. 2023 was HK$35,538 Mil. Therefore, Hansoh Pharmaceutical Group Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 31.38%.

Hansoh Pharmaceutical Group Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Gross-Profit-to-Asset % Chart

Hansoh Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

56.48

40.28

38.34

28.49

28.50

Hansoh Pharmaceutical Group Co Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial									38.74	28.21	29.73	25.42	31.38

Competitive Comparison of Hansoh Pharmaceutical Group Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hansoh Pharmaceutical Group Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Hansoh Pharmaceutical Group Co's Gross-Profit-to-Asset % falls into.

Hansoh Pharmaceutical Group Co Gross-Profit-to-Asset % Calculation

Hansoh Pharmaceutical Group Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	9923.793	/	( (33503.54	+	36137.447)	/ 2 )
	=	9923.793	/	34820.4935
	=	28.50 %

Hansoh Pharmaceutical Group Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	11150.378	/	( (34937.883	+	36137.447)	/ 2 )
	=	11150.378	/	35537.665
	=	31.38 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Hansoh Pharmaceutical Group Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » Gross-Profit-to-Asset %

Traded in Other Exchanges

3KY:Germany

Address

287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210

Website

https://www.hspharm.com

Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (HKSE:03692) Headlines

No Headlines